Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. scores highest on Torque (62) and lowest on Nitro (8). Its PosiPenta is 37.60 out of 100, weaker than most similar companies.
On the Penta Grid this week, Sionna Therapeutics, Inc. is Grid #617 of 837 in the Healthcare sector in United States, and Grid #3,102 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Sionna Therapeutics, Inc. | 37.60 | 44 | 26 | 8 | 62 | 48 |
| Oramed Pharmaceuticals Inc. | 74.51 | 92 | 49 | 77 | 90 | 65 |
| OptimizeRx Corporation | 58.71 | 54 | 86 | 42 | 62 | 49 |
| Sutro Biopharma, Inc. | 39.16 | 0 | 35 | 31 | 93 | 38 |
| Korro Bio, Inc. | 31.00 | 37 | 34 | 25 | 31 | 27 |
| ALX Oncology Holdings Inc. | 43.76 | 39 | 52 | 37 | 44 | 47 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.80 |
| P/B ratio | 0.66 |
EEarnings
| Trailing EPS | ₹-204.58 |
| Forward EPS | ₹-211.31 |
NNitro
| Price | 368.44 |
| 52-week high | 5206.48 |
| 52-week low | 357.55 |
| Fall from 52-week high | 92.9% |
TTorque
| Return on equity (ROE) | -32.34% |
| Debt-to-equity | 0.03 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹1,663 Cr |
| Insider holding | 7.88% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Sionna Therapeutics, Inc.'s PosiPenta score?
Sionna Therapeutics, Inc.'s PosiPenta is 37.60 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Sionna Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Sionna Therapeutics, Inc. is Grid #617 of 837 in the Healthcare sector in United States, and Grid #3,102 of 4,000 in United States.
Which PosiPenta pillar is strongest for Sionna Therapeutics, Inc.?
Torque (durability), with a score of 62 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Sionna Therapeutics, Inc.?
Nitro (momentum), with a score of 8 out of 100: much weaker than most similar companies.
Has Sionna Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.44 points, from 35.16 to 37.60.
PositoAI is for research and education only and is not investment advice.